| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/22/2011 | WO2011115268A1 Tumor angiogenesis inhibitor |
| 09/22/2011 | WO2011115231A1 Osteopontin specific monoclonal antibody |
| 09/22/2011 | WO2011115225A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 09/22/2011 | WO2011113882A1 Diagnosis and treatment of cancer based on avl9 |
| 09/22/2011 | WO2011113872A1 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of gastric cancer and other cancers |
| 09/22/2011 | WO2011113869A1 Canine astrovirus astv strain bari/08 identified in dogs with gastro-enteritis |
| 09/22/2011 | WO2011113801A1 Use of clostridium perfringens strain 23 to protect against necrotic enteritis |
| 09/22/2011 | WO2011113618A1 Immune therapy |
| 09/22/2011 | WO2011113546A1 Tumor vaccination involving a humoral immune response against self-proteins |
| 09/22/2011 | WO2011113308A1 New humanized anti-cd20 monoclonal antibody |
| 09/22/2011 | WO2011113160A1 Bacterial vaccine components from staphylococcus aureus and uses thereof |
| 09/22/2011 | WO2011094731A3 Methods for diagnosis and treatment of non-insulin dependent diabetes mellitus |
| 09/22/2011 | WO2011094465A4 Methods of treating autoimmune diseases with dll4 antagonists |
| 09/22/2011 | WO2011091113A3 Detection of early-stage pancreatic adenocarcinoma |
| 09/22/2011 | WO2011088288A8 Hybridoma cell lines and monoclonal antibodies recognizing anthrose saccharide of bacillus anthracis |
| 09/22/2011 | WO2011066369A3 Antagonists of il-6 to raise albumin and/or lower crp |
| 09/22/2011 | WO2011054011A4 Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom |
| 09/22/2011 | WO2011053798A3 Peptide compositions and methods for inhibiting herpesvirus infection |
| 09/22/2011 | WO2011050263A3 Systemic immunosuppression in the treatment of age related macular degeneration and diabetic retinopathy |
| 09/22/2011 | WO2011047031A3 Eliciting immune responses using recombinant mva viruses expressing hiv env, gag and pol anitgens |
| 09/22/2011 | WO2011044516A3 Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
| 09/22/2011 | WO2011031833A3 Human anti-cancer antibodies |
| 09/22/2011 | WO2010093706A8 Chemically programmed vaccination |
| 09/22/2011 | US20110230512 Pharmaceutical Composition |
| 09/22/2011 | US20110229576 Hollow silica nanospheres and methods of making same |
| 09/22/2011 | US20110229568 Michael systems as transglutaminase inhibitors |
| 09/22/2011 | US20110229556 Lipid-coated polymer particles for immune stimulation |
| 09/22/2011 | US20110229552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGIN |
| 09/22/2011 | US20110229551 Drug delivery compositions and methods using nanofiber webs |
| 09/22/2011 | US20110229550 Acid-Degradable and Bioerodible Modified Polyhydroxylated Materials |
| 09/22/2011 | US20110229546 Treatment of dissection, aneurysm, and atherosclerosis using granzyme b inhibitors |
| 09/22/2011 | US20110229524 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of Gastric Cancer and other cancers |
| 09/22/2011 | US20110229523 Modification of allergens for immunotherapy |
| 09/22/2011 | US20110229522 Methods, compositions and vaccines relating to neisseria meningitidis antibodies |
| 09/22/2011 | US20110229520 Mutant pestivirus with mutations in core gene and ns3 region |
| 09/22/2011 | US20110229519 Vaccine composition for use against influenza |
| 09/22/2011 | US20110229518 Optimized influenza vaccines |
| 09/22/2011 | US20110229517 System and process for producing multi-component biopharmaceuticals |
| 09/22/2011 | US20110229516 Adjuvant phase inversion concentrated nanoemulsion compositions |
| 09/22/2011 | US20110229515 Identification of genes |
| 09/22/2011 | US20110229514 Vaccine and immunization method using plasmodium antigen 2 |
| 09/22/2011 | US20110229513 LPS Based Vaccines |
| 09/22/2011 | US20110229512 Compositions and methods for diagnosing and treating urinary tract infections |
| 09/22/2011 | US20110229511 Method of modifying the immune response |
| 09/22/2011 | US20110229510 Glycopeptide constructs and uses thereof |
| 09/22/2011 | US20110229509 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229508 Polypeptides for inducing a protective immune response against staphylococcus aureus |
| 09/22/2011 | US20110229507 Stable anthrax vaccine formulations |
| 09/22/2011 | US20110229506 Method for cancer immunotherapy |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229504 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 09/22/2011 | US20110229503 Vaccination against malignant melanoma using bcg and/or vaccinia |
| 09/22/2011 | US20110229502 Ablative immunotherapy |
| 09/22/2011 | US20110229500 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 09/22/2011 | US20110229499 Method for treatment of vascular hyperpermeability |
| 09/22/2011 | US20110229498 Compositions and methods for modulating an immune response |
| 09/22/2011 | US20110229497 Modulating the Alternative Complement Pathway |
| 09/22/2011 | US20110229496 Method for regulating survival and memory of t helper 1 cells |
| 09/22/2011 | US20110229495 Methods for predicting development of auto-immune diseases and treatment of same |
| 09/22/2011 | US20110229494 Teneurin and cancer |
| 09/22/2011 | US20110229493 Neuregulin antagonists and use thereof in treating cancer |
| 09/22/2011 | US20110229492 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 09/22/2011 | US20110229491 Minichromosome maintenance complex interacting protein involved in cancer |
| 09/22/2011 | US20110229490 Lyophilized Formulations of Engineered Anti-IL-23p19 Antibodies |
| 09/22/2011 | US20110229489 Antibodies with pH Dependent Antigen Binding |
| 09/22/2011 | US20110229488 Progastrin and liver pathologies |
| 09/22/2011 | US20110229487 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient |
| 09/22/2011 | US20110229486 Monoclonal Antibodies Against NKG2A |
| 09/22/2011 | US20110229485 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 09/22/2011 | US20110229484 Host Cell Kinases as Targets for Antiviral Therapies Against HCV Infection |
| 09/22/2011 | US20110229483 Tumor angiogenesis associated genes and a method for their identification |
| 09/22/2011 | US20110229482 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood by preventing viral entry into a cell |
| 09/22/2011 | US20110229481 Cancer-associated antigen analogue peptides and uses thereof |
| 09/22/2011 | US20110229480 Pta072 protein |
| 09/22/2011 | US20110229479 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229477 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229475 Novel compounds |
| 09/22/2011 | US20110229474 Monitoring and inhibiting human immunodeficiency virus infection by modulating hmgb1 dependent triggering of hiv-1 replication and persistence |
| 09/22/2011 | US20110229473 Methods for using taci-immunoglobulin fusion proteins |
| 09/22/2011 | US20110229472 Peptides and Related Compounds Having Thrombopoietic Activity |
| 09/22/2011 | US20110229471 Methods of determining responsiveness to anti-tnf alpha therapy in inflammatory bowel disease |
| 09/22/2011 | US20110229470 Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis |
| 09/22/2011 | US20110229469 Methods for the treatment of cancer |
| 09/22/2011 | US20110229468 Targeting pax2 for the treatment of breast cancer |
| 09/22/2011 | US20110229467 Targeting pax2 for the treatment of breast cancer |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229465 Composition for treating disease |
| 09/22/2011 | US20110229464 Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues |
| 09/22/2011 | US20110229463 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/22/2011 | US20110229462 Hepatocyte Growth Factor (HGF) Binding Proteins |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229460 anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 09/22/2011 | US20110229459 Anti-nr10 antibody and use thereof |
| 09/22/2011 | US20110229458 Methods for selecting protease resistant polypeptides |
| 09/22/2011 | US20110229457 Injectable drug delivery system |
| 09/22/2011 | US20110229456 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | US20110229413 Treatment of amyloidogenic diseases |